The HMG‐CoA Reductase Inhibitor Fluvastatin Promotes Th2‐Skewed Immune Responses by Modulating Dendritic Cell Differentiation
Satoshi Ishikawa, Haruka Mizuno, Kanon Murase, Kazuki Sasano, Isamu Ogawa, Yuka Itoh, Saotomo Itoh, Shigeaki Hida · 2026
Read The HMG‐CoA Reductase Inhibitor Fluvastatin Promotes Th2‐Skewed Immune Responses by Modulating Dendritic Cell Differentiation by Satoshi Ishikawa, Haruka Mizuno, Kanon Murase, Kazuki Sasano, Isamu Ogawa, Yuka Itoh, Saotomo Itoh, Shigeaki Hida (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13533597.txt.
Description
Satoshi Ishikawa and colleagues show that a cholesterol drug can tilt immune balance in mice, in work published in 2026. Statins block a key enzyme and lower lipids, but they also shape immune responses. How they guide helper T cell paths was still poorly understood before this study.
Mice given fluvastatin for seven days made less of one signal and more of another in spleen T cells. The shift favoured the Th2 path without changing total cell counts or main cell shares. A second statin did not share the effect, which points to cell uptake as a factor. Lab tests traced much of the effect to dendritic cells grown under steady drug exposure. Those cells gained a stronger Th2 guiding power.
Catalog record
| CREATOR | Satoshi Ishikawa, Haruka Mizuno, Kanon Murase, Kazuki Sasano, Isamu Ogawa, Yuka Itoh, Saotomo Itoh, Shigeaki Hida |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |